Rohit Vishnoi, Director at Insys Therapeutics, Inc. (INSY), bought 4,000 shares at $14.14 ($57K) on 2017-06-01, disclosed to the SEC on 2017-06-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.